FTV — Fortive Corporation

Fortive Corporation (FTV) Q1 2026 Earnings Call Summary

1. Key Financial Results and Metrics

• Total Revenue: Nearly $1.1 billion, up almost 8% year-over-year; core revenue growth of just over 5%.
• Adjusted EBITDA: $314 million, up 13% year-over-year; adjusted EBITDA margin expanded to just over 29%.
• Adjusted EPS: $0.70, reflecting over 25% growth year-over-year, marking the third consecutive quarter of double-digit adjusted EPS growth.
• Free Cash Flow: Generated $194 million in Q1, with a trailing twelve-month free cash flow conversion exceeding 100%.
• Share Repurchases: Approximately $500 million in share repurchases completed in Q1, reducing share count by over 10% since the spin-off.

2. Strategic Updates and Business Highlights

• Fortive Accelerator Strategy: Continued execution on three pillars—organic growth, disciplined capital allocation, and building investor trust.
• Innovation: Launched several AI-enhanced products, including Fluke's CertiFiber Max and Provation Mirror Documentation Assist in healthcare, driving customer engagement and revenue.
• Market Focus: Targeting high-growth sectors like data centers, defense, and healthcare, with investments in regional strategies in India and China.
• Recurring Revenue Growth: Continued strong performance in recurring revenue across segments, with double-digit growth in services at Fluke.

3. Forward Guidance and Outlook

• Adjusted EPS Guidance: Reaffirmed full-year adjusted EPS guidance of $2.90 to $3.00, with expectations trending towards the upper half of this range.
• Revenue Expectations: Anticipated full-year reported revenue around $4.3 billion, with core growth projected in the 2% to 3% range.
• Q2 and Q3 Outlook: Expected adjusted EPS to be broadly similar to Q1, with slight adjustments due to selling day impacts and market dynamics.

4. Bad News, Challenges, or Points of Concern

• Gross Margin Pressure: Adjusted gross margin declined slightly to just over 63%, impacted by tariffs and product mix.
• Hospital Spending Pressures: Ongoing caution in capital spending from hospitals, particularly in the U.S., could affect AHS segment performance.
• Market Dynamics: Potential headwinds from tariffs expected to persist through part of Q3, with a noted revenue headwind in Q4 due to fewer selling days.

5. Notable Q&A Insights

• Order Strength: Orders grew faster than revenue, indicating positive demand trends across segments, with Fluke and AHS showing strong order growth.
• AI Integration: Discussion on leveraging AI for product innovation, with positive early results from AI-driven initiatives in the FAL portfolio.
• M&A Strategy: Focus on bolt-on acquisitions remains a priority, with a revamped M&A team in place and a disciplined approach to capital allocation.
• Data Center Opportunities: Fluke's positioning in the data center market is seen as a significant growth opportunity, particularly with new product launches.

Overall, Fortive reported a strong start to 2026, with solid financial performance and strategic execution, while also navigating challenges related to market conditions and gross margin pressures.